Experience with an IL-1ß inhibitor (anakinra) in a patient with CINCA/NOMID syndrome

Experience with an IL-1ß inhibitor (anakinra) in a patient with CINCA/NOMID syndrome

Bibliographic Details
Main Authors:	S O Salugina, E S Fedorov, N N Kuzmina
Format:	Article
Language:	Russian
Published:	IMA-PRESS LLC 2012-09-01
Series:	Современная ревматология
Online Access:	https://mrj.ima-press.net/mrj/article/view/434

Similar Items

Cryopyrin-associated periodic syndromes (CAPS): report on two cases (Muckle-Wells syndrome (MWS) and CINCA/NOMID)
by: Kuzmina NN, et al.
Published: (2011-09-01)

EXPERIENCE IN APPLICATION OF CANAKINUMAB IN PATIENTS WITH CRYOPYRIN-ASSOCIATED SYNDROME (SYNDROME CINCA/NOMID)
by: T. V. Sleptsova, et al.
Published: (2014-05-01)

Our experience with the use of the Interleukin-1 receptor antagonist in the treatment of the patient with CINCA/NOMID syndrome (case study - 5 years of therapy)
by: Vargova V, et al.
Published: (2011-09-01)

12.3 Long-term follow up of patients with CINCA syndrome: efficacy and tolerability of Anakinra treatment
by: Paloni G, et al.
Published: (2008-09-01)

The interleukin 1 inhibitor canakinumab in the treatment of cryopyrin-associated periodic syndromes (CAPS): clinical experience
by: Svetlana Olegovna Salugina, et al.
Published: (2014-12-01)

Homeostatic tissue responses in skin biopsies from NOMID patients with constitutive overproduction of IL-1β.
by: Pamela Aubert, et al.
Published: (2012-01-01)

Familial Mediterranean fever in Russia: Experience of the Federal Rheumatology Center
by: E. S. Fedorov, et al.
Published: (2017-04-01)

Síndrome CINCA: um diagnóstico diferencial da artrite idiopática juvenil CINCA syndrome: a differential diagnosis of the juvenile idiopathic arthritis
by: Erica Naomi Naka, et al.
Published: (2007-08-01)

Current approaches to diagnosis, treatment, and monitoring in patients with cryopyrin-associated periodic syndromes (CAPS)
by: S. O. Salugina, et al.
Published: (2016-06-01)

AHA syndrome (arthralgia, arthritis, hives, angioneuroticedema) in children (literature data and own observations description)
by: E S Fedorov, et al.
Published: (2005-08-01)

Autoinflammatory syndromes: What a rheumatologist should know
by: Evgeny Stanislavovich Fedorov, et al.
Published: (2012-06-01)

Schnitzler syndrome: A review of literature, the authors’ observation, and experience with the interleukin-1 inhibitor canakinumab
by: S O Salugina, et al.
Published: (2017-11-01)

Entrevista a Víctor Lorenzo Cinca
by: Víctor Santiago de Dios Menéndez
Published: (2018-05-01)

Entrevista a Víctor Lorenzo Cinca
by: Víctor Santiago de Dios Menéndez
Published: (2018-05-01)

BEHCET'S DISEASE IN CHILDREN: RUSSIAN EXPERIENCE
by: N. N. Kuzmina, et al.
Published: (2015-09-01)

Majeed syndrome: description of a novel mutation and therapeutic response to bisphosphonates and IL-1 blockade with anakinra
by: Roy, N, et al.
Published: (2019)

Recurrent poliserositis succesfully treated with IL-1 receptor antagonist Anakinra
by: Santa-María V, et al.
Published: (2011-09-01)

659 Blocking cytokine IL-1 with anakinra for the prevention of cytokine release syndrome in COVID-19
by: Jason Williams, et al.
Published: (2020-11-01)

CINCA Syndrome With New NLRP3 Mutation and Unreported Complication of Thyroid Carcinoma
by: Farhad Salehzadeh, et al.
Published: (2019-06-01)

Resolution of the Council of Excperts (16th June, 2022): Therapy of gouty arthritis with an IL-1 inhibitor (anakinra)
by: E. L. Nasonov, et al.
Published: (2022-12-01)

Nanorrelatos y microrrelatos, de Víctor Lorenzo Cinca
by: Víctor Lorenzo Cinca
Published: (2018-05-01)

Nanorrelatos y microrrelatos, de Víctor Lorenzo Cinca
by: Víctor Lorenzo Cinca
Published: (2018-05-01)

Development of the doctrine of auto-inflammatory diseases in the XXI century
by: E. S. Fedorov, et al.
Published: (2019-04-01)

Role of cytokine net in regulation of inflammation in different variants of juvenile arthritis
by: E S Fedorov, et al.
Published: (2009-06-01)

Familial mediterranean fever and pauciimmune renal vasculitis: the role of IL-1 blockade (Anakinra)
by: Sánchez A, et al.
Published: (2011-09-01)

AUTOINFLAMMATORY DISEASES IN RHEUMATOLOGY: RUSSIAN EXPERIENCE
by: S. O. Salugina, et al.
Published: (2016-07-01)

Problems in the treatment of rheumatoid arthritis and prospects for the use of an IL-1 inhibitor (Anakinra). (Resolution of the Expert Council, May 19, 2022)
by: article Editorial
Published: (2022-11-01)

Problems of immunopathology and prospects for pharmacotherapy of idiopathic recurrent pericarditis: Using an interleukin 1 inhibitor (Anakinra)
by: E. L. Nasonov, et al.
Published: (2023-03-01)

Fiver syndrom in pediatric rheumatology practice: from symptom to diagnosis
by: N N Kuzmina, et al.
Published: (2008-02-01)

The trials of anakinra.
by: Burls, A, et al.
Published: (2004)

Familial Mediterranean fever (a periodic disease): The present-day view of the problem
by: Evgeny Stanislavovich Fedorov, et al.
Published: (2013-03-01)

Familial Mediterranean fever (a periodic disease): The present-day view of the problem
by: Evgeny Stanislavovich Fedorov, et al.
Published: (2013-03-01)

The role of interleukin 1 in the development of human diseases: focus on Anakinra (IL-1 receptor antagonist)
by: E. L. Nasonov, et al.
Published: (2022-07-01)

The IL-1 Antagonist Anakinra Attenuates Glioblastoma Aggressiveness by Dampening Tumor-Associated Inflammation
by: Max Hübner, et al.
Published: (2020-02-01)

A familial case of Muckle-Wells syndrome in a Russian population: The first successes of therapy with the interleukin 1 inhibitor canakinumab
by: S. O. Salugina, et al.
Published: (2015-03-01)

Continuous IV infusion of anakinra
by: Brittney N. Saunders, et al.
Published: (2023-05-01)

Schnitzler syndrome refractory to anakinra: successful treatment with canakinumab
by: Angel Luis Salcedo-Mingoarranz, et al.
Published: (2023-12-01)

Intravenous administration of anakinra in children with macrophage activation syndrome
by: Omkar Phadke, et al.
Published: (2021-06-01)

Usefulness of interleukin 1 receptor antagonist (anakinra) in refractory post-pericardiotomy syndrome
by: Marta Flores Fernández, et al.
Published: (2021-09-01)

Autoinflammatory diseases – modern view on the problem
by: N N Kuzmina, et al.
Published: (2009-02-01)